Exploring myeloma vaccine therapy

(If you're not yet a fan, join us now by clicking the Like button)

In this video from the Myeloma 2014 meeting in Boston, Dr. David Avigan, from the Dana-Farber Cancer Institute, describes his latest research into cancer vaccines powered by so-called dendritic cells. He also discusses ongoing research into using these drugs together with approved immunomodulatory drugs, a combination which may offer new promise to attacking the toughest residual multiple myeloma.

Patient Power

Comments are closed.